Biosimilars, antiplatelets, oncolytics in the spotlight at ASHP
from Medscape (free login required)
Biosimilar drugs, antiplatelet therapy, and specialty medications — primarily oral oncolytics — will be among the hot topics discussed at the American Society of Health-System Pharmacists (ASHP) 2015 Midyear Clinical Meeting, according to one of the meeting's lead presenters. More than 20,000 professionals from 100 countries will attend the largest gathering of pharmacists, technicians, and pharmacy students in the United States.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063